Profilo
Kate E.
Broderick is Senior Vice President-Research & Development at TriLink BioTechnologies LLC since 2022.
Formerly, Dr. Broderick was Senior Vice President-Research & Development at Inovio Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Broderick was Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. from 2022 to 2025.
Dr. Broderick earned a doctorate from the University of Glasgow.
Posizioni attive di Kate Broderick
| Società | Posizione | Inizio |
|---|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
Precedenti posizioni note di Kate Broderick
| Società | Posizione | Fine |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2025 |
| INOVIO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2022 |
Formazione di Kate Broderick
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
















